1465 studies found for:    glioma
Show Display Options
Rank Status Study
1 Not yet recruiting A Phase I/II Study of Mebendazole for the Treatment of Pediatric Gliomas
Conditions: Pilomyxoid Astrocytoma;   Pilocytic Astrocytoma;   Glioma, Astrocytic;   Optic Nerve Glioma;   Pleomorphic Xanthoastrocytoma;   Glioblastoma Multiforme;   Anaplastic Astrocytoma;   Gliosarcoma;   Diffuse Intrinsic Pontine Glioma;   DIPG;   Low-grade Glioma
Interventions: Drug: Mebendazole;   Drug: Vincristine;   Drug: Carboplatin;   Drug: Temozolomide;   Drug: Bevacizumab;   Drug: Irinotecan
2 Unknown  Gene Expression, Immunological Status and Metabolome in Glioma Patients
Condition: Glioma
Interventions: Procedure: Glioma resection;   Other: Blood sampling
3 Recruiting A Pilot Study of Glioma Associated Antigen Vaccines in Conjunction With Poly-ICLC in Pediatric Gliomas
Conditions: Newly Diagnosed Pediatric Pontine Glioma.;   Newly Diagnosed Pediatric High Grade Glioma.;   Recurrent Pediatric High Grade Glioma.;   Recurrent Pediatric Low Grade Glioma.
Interventions: Biological: HLA-A2 restricted glioma antigen peptides vaccine;   Biological: Poly-ICLC
4 Active, not recruiting Low-Dose Naltrexone for Glioma Patients
Condition: Malignant Glioma
Interventions: Drug: Naltrexone;   Other: Placebo
5 Active, not recruiting A Study of Bevacizumab Therapy in Patients With Newly Diagnosed High-Grade Gliomas and Diffuse Intrinsic Pontine Gliomas
Conditions: Newly Diagnosed High-Grade Gliomas;   Diffuse Intrinsic Pontine Glioma
Interventions: Drug: Temozolomide;   Drug: Bevacizumab;   Drug: Irinotecan
6 Recruiting Fluorescence and Glioma Heterogeneity
Condition: Malignant Gliomas
Intervention: Procedure: ALA Test group
7 Completed An Open-label, Phase I/IIa, Dose Escalating Study of 2B3-101 in Patients With Solid Tumors and Brain Metastases or Recurrent Malignant Glioma.
Conditions: Brain Metastases;   Lung Cancer;   Breast Cancer;   Melanoma;   Malignant Glioma
Interventions: Drug: 2B3-101;   Drug: Trastuzumab;   Drug: 2B3-101 60 mg/m2 every 4 weeks;   Drug: 2B3-101 50 mg/m2 every 3 weeks
8 Completed Phase IIa Safety and Light Dose-escalation Study in Patients With Primary or Recurrent/High-grade Glioma Using the Litx™ System to Confirm the Zone of Tumor Destruction During the Intraoperative Treatment of Glioma
Conditions: Glioma;   Glioblastoma Multiforme;   Anaplastic Astrocytoma
Interventions: Drug: LS11 (talaporfin sodium);   Device: Light source (interstitial light emitting diodes);   Procedure: Intraoperative placement of device in glioma
9 Completed A Study of XL765 (SAR245409) in Combination With Temozolomide With and Without Radiation in Adults With Malignant Gliomas
Conditions: Mixed Gliomas;   Malignant Gliomas;   Glioblastoma Multiforme
Interventions: Drug: XL765 (SAR245409);   Drug: Temozolomide
10 Recruiting Identification of Clinically Occult Glioma Cells and Characterization of Glioma Behavior Through Machine Learning Analysis of Advanced Imaging Technology
Condition: Glioma
Interventions: Procedure: MRS Imaging;   Procedure: PET Scanning;   Procedure: Diffusion Tensor Imaging
11 Completed A Phase II Study to Treat Advanced Malignant Glioma
Condition: Advanced Malignant Glioma
Interventions: Drug: AMG 102 at 20 mg/kg;   Drug: AMG 102 at 10 mg/kg
12 Completed AZD8055 for Adults With Recurrent Gliomas
Conditions: Glioblastoma Multiforme;   Anaplastic Astrocytoma;   Anaplastic Oligodendroglioma;   Malignant Glioma;   Brainstem Glioma
Intervention: Drug: AZD8055
13 Enrolling by invitation Permeability Map to Distinguish Progression From Pseudoprogression in High-Grade Glioma
Condition: High Grade Glioma
Intervention:
14 Completed Ph. II Temozolomide + O6-BG in Treatment of Pts w Temozolomide-Resistant Malignant Glioma
Conditions: Glioblastoma Multiforme;   Anaplastic Glioma
Intervention: Drug: Temodar and O6-Benzylguanine (BG)
15 Suspended Re-irradiation of High Grade Gliomas: a Quality of Life Study
Conditions: Anaplastic Astrocytoma;   Glioblastoma Multiforme;   Anaplastic Oligoastrocytoma
Interventions: Other: EORTC QLQ-C30;   Other: EORTC QLQ-BN20;   Other: Hopkins Verbal Learning Test-Revised (HVLT-R);   Other: Stroop color-word test;   Other: Controlled oral word association test (COWA);   Other: Jamar hand dynamometer;   Other: EORTC QLQ- FA13;   Other: Trail Making Test (TMT)
16 Unknown  131-I-TM-601 Study in Adults With Recurrent High-Grade Glioma
Conditions: Malignant Glioma;   Glioblastoma Multiforme;   GBM;   Anaplastic Astrocytoma;   Oligo-Astrocytoma;   Gliosarcoma
Interventions: Drug: 131-I-TM-601;   Drug: 131I-TM601
17 Recruiting Rotating Frame Relaxation and Diffusion Weighted Imaging of Human Gliomas
Conditions: Low Grade Glioma;   Malignant Glioma
Intervention:
18 Recruiting 68Ga-NOTA-NFB: Radiation Dosimetry in Healthy Volunteers and Applications in Glioma Patients or Breast Cancer Patients
Conditions: Glioma;   Breast Cancer
Intervention: Radiation: 68Ga-NOTA-NFB
19 Completed
Has Results
Thalidomide and Temozolomide or Camptothecin-11 (CPT-11) in Patients With Gliomas
Conditions: Glioblastoma Multiforme;   Glioma
Interventions: Drug: Thalidomide;   Drug: CPT-11;   Procedure: MRI Scan;   Procedure: Quantitative Sensory Tests  (QST)
20 Recruiting Anti PD1 Antibody in Diffuse Intrinsic Pontine Glioma and Relapsed Glioblastoma Multiforme
Condition: Malignant Gliomas
Intervention: Biological: CT-011

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years